Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

Rcan2-mediated decrease in intracellular K⁺ involves Kcnk5b. by Xiaowen Jiang (8291814)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Decreased S100A9 expression alleviates Clostridium perfringens beta2 toxin-induced inflammatory injury in IPEC-J2 cells by Jie Li (13877648)

“…<p><strong>Decreased </strong><em><strong>S100A9</strong></em><strong> expression alleviates </strong><em><strong>Clostridium perfringens</strong></em><strong> beta2 toxin-induced inflammatory injury in IPEC-J2 cells</strong></p>…”

PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. by Jiayu Liu (3951515)

DCD is strikingly decreased in HS lesions. by Margaret Coates (6058580)

“…<p>(A) qPCR for <i>DCD</i> (log₂FC = -3.57, *p < 0.05). …”

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)

rRL-KD treatment decreased inflammation after MSU-induced acute gout arthritis. by Fábio Mambelli (10005409)

Inhibition of the mitochondrial fission decreases mtROS production. by Dong Ma (584680)

Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake. by Jeffrey M. McManus (7512926)

DJA2 decreases maturation of CFTR. by Patrick Kim Chiaw (7224539)

HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity - Fig 2 by Qin Huang (49441)

Subjects:

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

CCR2 depletion decreases lipid accumulation in the liver and WAT. by Seung Joo Lee (1766020)

“…Markedly increased concentration of GOT and GPT in HFD WT was significantly decreased in CCR2 KO. (c) Adiposity size of WAT was measured by Image J software. …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)